Drugs / metoprolol extended release
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00732511 Comparator | Apr → Dec 2008 | diabetes mellitus, hypertensive disorder | State University of New York - Downstate Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | metoprolol extended release | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00732511 ↗ |
| Action | Inhibit | “both drugs reduce blood pressure by blocking the action of noradrenaline on beta-receptors in the blood vessels” NCT00732511 ↗ |